Shore Capital-Backed SENTA Partners Acquires Advanced ENT and Allergy

Shore Capital-Backed SENTA Partners Acquires Advanced ENT and Allergy

Southern Ear Nose Throat & Allergy (SENTA) Partners, a portfolio company of private equity firm Shore Capital Partners, has announced a new partnership with Advanced ENT and Allergy, with locations in Kentucky and Indiana.  Advanced ENT and Allergy is a leading ear, throat & nose (ENT) and allergy practice in the Southern United States, with nearly 170 employees across six locations. According to its website, there are 14 physicians on staff.  Founded in 2019, SENTA Partners is an ENT and allergy management services organization with more than 930 employees, including 180 providers across 66 locations in seven states.  This partnership further solidifies SENTA’s... Read More »
PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm

PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm

Chicago-based private equity firm Shore Capital Partners announced the sale of Argentum Medical to BioDerm, a portfolio company of Denver-based private equity firm Mountaingate Capital. The transaction closed on January 31, 2023. Moelis & Company served as financial advisor to Argentum and Winston & Strawn LLP served as legal advisor to Shore and Argentum. Terms of the deal were not disclosed. Based in Geneva, Illinois, Argentum is a provider of infection prevention solutions for the management of wounds. Notably, it manufactures Silverlon, a silver-plated nylon dressing with unique antimicrobial properties. Argentum’s product lines include surgical, burn care, wound care, negative... Read More »
Ophthalmology Groups Are Still Hot Targets

Ophthalmology Groups Are Still Hot Targets

It’s been an incredibly busy January, and deal volume continues to pile up. Investor interest in physician groups has swelled in particular, as we reach 36 deals and counting. The hottest specialty so far has been for ophthalmology practices, which have accounted for seven deals so far this month.  It’s a trend that has spilled over from 2020, when ophthalmology deals accounted for 22% of the 189 Physician Medical Group transactions announced last year. As other specialties, such as dental practices and dermatology groups, were hit hard by the pandemic, demand for cataract surgery and the ability to conduct eye exams and other routine care via telehealth grew, resulting in increasing... Read More »
Ophthalmology Groups Are Still Hot Targets

EyeSouth Partners Adds Another Texas Physician Group

The private equity-backed EyeSouth Partners is closing 2020 on a strong note. With the support of Shore Capital Partners, EyeSouth Partners added Eye Center of Texas (ECT), which employs 14 physicians across six primary clinical locations in the greater Houston area and provides an integrated service model incorporating the latest advancements in cataract surgery, retina management, glaucoma treatment, refractive surgery and routine eye exams.  EyeSouth Partners is an eye care services organization in the southeast. Its affiliate network consists of 114 doctors providing medical and surgical eye care services at approximately 70 locations, including 11 surgery centers, in Alabama, Florida,... Read More »
Physician Practices Find Many Buyers

Physician Practices Find Many Buyers

The first quarter of 2018 is nearly over (one week left to go), and the Physician Medical Group sector is still in acquisition mode. Last year, the first quarter saw a record 59 deals announced for physician groups. This year’s Q1 total won’t challenge that, but the 30 deals reported so far show interest isn’t waning for buyers or sellers. We’ve written extensively about private equity groups building platforms of specialty practices, particularly dermatology, anesthesia and ophthalmology. But publicly traded entities are still in the hunt. In the first three weeks of March 2018, 13 deals for physician practices were announced, although none disclosed financial... Read More »